跳转至内容
Merck
CN

S8688

SR 59230A

≥98% (HPLC), powder, β3-Adrenoceptor antagonist

别名:

3-(2-乙基苯氧基)-1-[[(1S)-1,2,3,4-四氢萘-1-基]氨基]-(2S)-2-丙醇 草酸盐

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C21H27NO2 · C2H2O4
化学文摘社编号:
分子量:
415.48
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
MDL number:
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

SR 59230A, ≥98% (HPLC), powder

Quality Level

assay

≥98% (HPLC)

form

powder

color

white

solubility

DMSO: >10 mg/mL, H2O: insoluble

originator

Sanofi Aventis

SMILES string

OC(=O)C(O)=O.CCc1ccccc1OC[C@@H](O)CN[C@H]2CCCc3ccccc23

InChI

1S/C21H27NO2.C2H2O4/c1-2-16-8-4-6-13-21(16)24-15-18(23)14-22-20-12-7-10-17-9-3-5-11-19(17)20;3-1(4)2(5)6/h3-6,8-9,11,13,18,20,22-23H,2,7,10,12,14-15H2,1H3;(H,3,4)(H,5,6)/t18-,20-;/m0./s1

InChI key

XTBQNQMNFXNGLR-MKSBGGEFSA-N

Gene Information

human ... ADRB3(155)

Application

SR 59230A用于& # 946;大鼠主动脉中的肾上腺素受体。3经测试,它被认为是一种改善心力衰竭大鼠模型心脏功能的潜在治疗剂。4

Biochem/physiol Actions

SR 59230A是一种& # 946;3-肾上腺素受体拮抗剂。它对& # 946;有很高的亲和力。3肾上腺素能受体出现在人体肠道中,影响人体结肠循环平滑肌的功能。1据报道SR 59230A抑制心脏钾通道2.1-2.3。2

Features and Benefits

该化合物在受体分类和信号转导手册中β-肾上腺素受体页面中进行了详细介绍。想要浏览手册的其他页面, 请单击此处
该化合物由Sanofi Aventis开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处


存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Run-tao Gan et al.
Chinese medical journal, 120(24), 2250-2255 (2008-01-03)
Stimulation of the heart beta 3-adrenoceptor (AR) may result in a negative inotropic effect. Being up-regulated, beta 3-AR plays a more important role in the regulation of cardiac function during heart failure. However, the effect of chronic blocking of beta
Maria Antonietta Maselli et al.
European journal of pharmacology, 723, 62-66 (2013-11-28)
The effect of two novel β3-adrenoceptor (β3-AR) agonists SP-1f and SP-1h on human colon circular smooth muscle contractility and β3-AR mRNA expression have been determined. β3-AR is ascertained co-participates to the control of the gut motility. Isometric tension on human
Elena Butturini et al.
European journal of pharmacology, 730, 107-115 (2014-03-15)
The aim of this study was to investigate the effect of costunolide (CS) and dehydrocostuslactone (DCE) a well-known sesquiterpene lactones contained in many plants, in a model of lung injury induced by carrageenan administration in the mice. Injection of carrageenan



全球贸易项目编号

货号GTIN
S8688-25MG04061836960988
S8688-5MG04061836960995